David Rescott
Stock Analyst at Baird
(3.70)
# 746
Out of 5,147 analysts
80
Total ratings
61.29%
Success rate
6.05%
Average return
Main Sectors:
Top Industries:
Stocks Rated by David Rescott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDT Medtronic | Maintains: Neutral | $103 → $100 | $97.66 | +2.40% | 9 | Feb 18, 2026 | |
| BSX Boston Scientific | Maintains: Outperform | $118 → $101 | $76.85 | +31.42% | 10 | Feb 5, 2026 | |
| PEN Penumbra | Downgrades: Neutral | $345 → $374 | $344.39 | +8.60% | 32 | Jan 16, 2026 | |
| SIBN SI-BONE | Maintains: Buy | $21 → $23 | $15.52 | +48.20% | 8 | Dec 18, 2025 | |
| EW Edwards Lifesciences | Maintains: Neutral | $88 → $87 | $86.47 | +0.61% | 7 | Dec 16, 2025 | |
| HAE Haemonetics | Maintains: Outperform | $87 → $99 | $63.32 | +56.35% | 2 | Dec 15, 2025 | |
| LIVN LivaNova | Maintains: Outperform | $63 → $70 | $70.60 | -0.85% | 6 | Nov 13, 2025 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $111 → $110 | $77.18 | +42.52% | 3 | Apr 25, 2025 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $600 → $575 | $503.51 | +14.20% | 3 | Apr 23, 2025 |
Medtronic
Feb 18, 2026
Maintains: Neutral
Price Target: $103 → $100
Current: $97.66
Upside: +2.40%
Boston Scientific
Feb 5, 2026
Maintains: Outperform
Price Target: $118 → $101
Current: $76.85
Upside: +31.42%
Penumbra
Jan 16, 2026
Downgrades: Neutral
Price Target: $345 → $374
Current: $344.39
Upside: +8.60%
SI-BONE
Dec 18, 2025
Maintains: Buy
Price Target: $21 → $23
Current: $15.52
Upside: +48.20%
Edwards Lifesciences
Dec 16, 2025
Maintains: Neutral
Price Target: $88 → $87
Current: $86.47
Upside: +0.61%
Haemonetics
Dec 15, 2025
Maintains: Outperform
Price Target: $87 → $99
Current: $63.32
Upside: +56.35%
LivaNova
Nov 13, 2025
Maintains: Outperform
Price Target: $63 → $70
Current: $70.60
Upside: -0.85%
Merit Medical Systems
Apr 25, 2025
Maintains: Outperform
Price Target: $111 → $110
Current: $77.18
Upside: +42.52%
Intuitive Surgical
Apr 23, 2025
Maintains: Outperform
Price Target: $600 → $575
Current: $503.51
Upside: +14.20%